NCT00114231 Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer Status COMPLETED Phase PHASE2
NCT00112918 Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer Status COMPLETED Phase PHASE3
NCT00112658 Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT00112528 Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00104689 Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00104676 Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors Status COMPLETED Phase PHASE3
NCT00103298 Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00101270 Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas Status COMPLETED Phase PHASE1
NCT00101205 Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma Status TERMINATED Phase PHASE1
NCT00100841 Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00098982 Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00098787 Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00096278 Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer Status COMPLETED Phase PHASE3
NCT00096070 Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00093652 Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00093379 Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer Status COMPLETED Phase PHASE2
NCT00091182 Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment Status COMPLETED Phase PHASE2
NCT00089024 Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00087334 Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer Status TERMINATED Phase PHASE1/PHASE2